Institute for Protein Innovation Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
The Institute for Protein Innovation (IPI) is a nonprofit biotechnology research organization based in Boston, Massachusetts. It provides synthetic antibodies and deep protein expertise to the biomedical research community to support fundamental biology and identify targets for therapeutic development. The organization employs 51 to 200 people and is headquartered at 4 Blackfan Circle in Boston. IPI pursues collaborative projects and programs, including a 2023 partnership with Addgene to accelerate discovery and distribution of recombinant antibodies and related reagents, and a 2026 antibody discovery collaboration with Alloy Therapeutics; in 2025 it launched the Springer-Lu Postdoctoral Fellowship. The institution has a history of leadership changes and program development, including the 2022 appointment of Kenneth Fasman as President and CEO, a 2024 commercialization leadership transition, and prior efforts such as open-source monoclonal antibody initiatives.